Brief: Turnstone Biologics to Be Acquired by XOMA for $0.34/Share Plus Contingent Value Right
27/06/2025 12:32
June 27 (Reuters) - Turnstone Biologics Corp TSBX.O: TURNSTONE BIOLOGICS CORP. ENTERS INTO AGREEMENT TO BE ACQUIRED BY XOMA ROYALTY CORPORATION FOR $0.34 IN CASH PER SHARE PLUS A CONTINGENT VALUE RIGHT TURNSTONE BIOLOGICS CORP - DEAL VALUED AT $0.34 PER SHARE PLUS CVR Source text: ID:nGNX6hGWnv Further company coverage: TSBX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Turnstone Biologics
See all newsBrief: Turnstone Biologics to Be Acquired by XOMA for $0.34/Share Plus Contingent Value Right
U.S. STOCKS ON THE MOVE-Walmart, crypto, banks
Turnstone rises as company cuts job, changes executives
Brief: Turnstone Biologics Sees One-Time Severance-Related Charge Associated With Workforce Reduction To Be About $2.3 Million
Brief: Turnstone Biologics Announces Strategic Restructuring To Prioritize Portfolio And Extend Financial Runway